Alzheimer Europe Conference: Symposium on rethinking the early detection and diagnosis of Alzheimer’s disease
Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health needs. It represents between 60% and 70% of the dementia cases. It is still diagnosed too late when the symptoms become evident as the disease progresses. AD is now portrayed as continuum consisting of 3 stages: [...]